Skip to main content
Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
4.030
-0.080 (-1.95%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Oramed Pharmaceuticals Revenue

In the year 2025, Oramed Pharmaceuticals had annual revenue of $2.00M.

Revenue (ttm)
$2.00M
Revenue Growth
n/a
P/S Ratio
81.50
Revenue / Employee
$500,000
Employees
4
Market Cap
163.00M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20252.00M--
Dec 31, 2024---
Dec 31, 20231.34M-1.36M-50.43%
Dec 31, 20222.70M-9.00K-0.33%
Dec 31, 20212.71M9.00K0.33%
Aug 31, 2021 Pro Pro Pro
Dec 31, 2020 Pro Pro Pro
Aug 31, 2020 Pro Pro Pro
Aug 31, 2019 Pro Pro Pro
Aug 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Agenus 114.20M
Black Diamond Therapeutics 70.00M
Protalix BioTherapeutics 52.74M
ProQR Therapeutics 19.19M
Tonix Pharmaceuticals Holding 13.11M
Humacyte 2.04M
Molecular Partners AG 856.30K
Revenue Rankings

ORMP News

More News